97 related articles for article (PubMed ID: 25906117)
1. p16 Expression in Prostate Cancer and Nonmalignant Lesions: Novel Findings and Review of the Literature.
Remo A; Pancione M; Zanella C; Manfrin E
Appl Immunohistochem Mol Morphol; 2016 Mar; 24(3):201-6. PubMed ID: 25906117
[TBL] [Abstract][Full Text] [Related]
2. P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies.
Beach R; Gown AM; De Peralta-Venturina MN; Folpe AL; Yaziji H; Salles PG; Grignon DJ; Fanger GR; Amin MB
Am J Surg Pathol; 2002 Dec; 26(12):1588-96. PubMed ID: 12459625
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic usefulness of monoclonal antibody P504S in the workup of atypical prostatic glandular proliferations.
Kunju LP; Rubin MA; Chinnaiyan AM; Shah RB
Am J Clin Pathol; 2003 Nov; 120(5):737-45. PubMed ID: 14608901
[TBL] [Abstract][Full Text] [Related]
4. P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy.
Jiang Z; Wu CL; Woda BA; Dresser K; Xu J; Fanger GR; Yang XJ
Am J Surg Pathol; 2002 Sep; 26(9):1169-74. PubMed ID: 12218573
[TBL] [Abstract][Full Text] [Related]
5. Expression of alpha-Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate.
Yang XJ; Wu CL; Woda BA; Dresser K; Tretiakova M; Fanger GR; Jiang Z
Am J Surg Pathol; 2002 Jul; 26(7):921-5. PubMed ID: 12131160
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of a p63/alpha-methyl coenzyme A racemase (p504s) cocktail in ambiguous lesions of the prostate upon needle biopsy.
Molinié V; Hervé JM; Lugagne PM; Lebret T; Botto H
BJU Int; 2006 May; 97(5):1109-15. PubMed ID: 16643500
[TBL] [Abstract][Full Text] [Related]
7. Comparison of monoclonal antibody (P504S) and polyclonal antibody to alpha methylacyl-CoA racemase (AMACR) in the work-up of prostate cancer.
Kunju LP; Chinnaiyan AM; Shah RB
Histopathology; 2005 Dec; 47(6):587-96. PubMed ID: 16324196
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of p63 and α-methyl acyl Co A racemase in resolving suspicious foci in prostatic needle biopsy and transurethral resection of prostate specimens.
Singh V; Manu V; Malik A; Dutta V; Mani NS; Patrikar S
J Cancer Res Ther; 2014; 10(3):686-92. PubMed ID: 25313761
[TBL] [Abstract][Full Text] [Related]
9. Detection of prostate cancer by alpha-methylacyl CoA racemase (P504S) in needle biopsy specimens previously reported as negative for malignancy.
Carswell BM; Woda BA; Wang X; Li C; Dresser K; Jiang Z
Histopathology; 2006 May; 48(6):668-73. PubMed ID: 16681682
[TBL] [Abstract][Full Text] [Related]
10. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.
Chen YB; Fine SW; Epstein JI
Am J Surg Pathol; 2011 Jul; 35(7):1054-61. PubMed ID: 21606823
[TBL] [Abstract][Full Text] [Related]
11. P504S: a new molecular marker for the detection of prostate carcinoma.
Jiang Z; Woda BA; Rock KL; Xu Y; Savas L; Khan A; Pihan G; Cai F; Babcook JS; Rathanaswami P; Reed SG; Xu J; Fanger GR
Am J Surg Pathol; 2001 Nov; 25(11):1397-404. PubMed ID: 11684956
[TBL] [Abstract][Full Text] [Related]
12. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
Noguchi M; Stamey TA; McNeal JE; Yemoto CM
J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of p63 and p504s markers for the diagnosis of prostate cancer].
Molinié V; Vieillefond A; Michiels JF;
Ann Pathol; 2008 Oct; 28(5):417-23. PubMed ID: 19068396
[TBL] [Abstract][Full Text] [Related]
14. [Promotor hypermethylation of E-cadherin, p16 and estrogen receptor in prostate carcinoma].
Yao Q; He XS; Zhang JM; He J
Zhonghua Nan Ke Xue; 2006 Jan; 12(1):28-31. PubMed ID: 16483154
[TBL] [Abstract][Full Text] [Related]
15. An analysis of the p63/alpha-methylacyl coenzyme A racemase immunohistochemical cocktail stain in prostate needle biopsy specimens and tissue microarrays.
Sanderson SO; Sebo TJ; Murphy LM; Neumann R; Slezak J; Cheville JC
Am J Clin Pathol; 2004 Feb; 121(2):220-5. PubMed ID: 14983935
[TBL] [Abstract][Full Text] [Related]
16. Cysteine-rich secretory protein 3 and β-microseminoprotein on prostate cancer needle biopsies do not have predictive value for subsequent prostatectomy outcome.
Hoogland AM; Dahlman A; Vissers KJ; Wolters T; Schröder FH; Roobol MJ; Bjartell AS; van Leenders GJ
BJU Int; 2011 Oct; 108(8):1356-62. PubMed ID: 21410630
[TBL] [Abstract][Full Text] [Related]
17. [Association between Proposed Cancer Foci from the Results of Systematic 12-Core Transrectal Needle Biopsies and Actual Cancer Foci from Radical Prostatectomy Specimens].
Takeuchi Y; Sekido N; Kinno K; Sawada Y; Kuroda K; Oharaseki T
Hinyokika Kiyo; 2015 Jun; 61(6):235-9. PubMed ID: 26153052
[TBL] [Abstract][Full Text] [Related]
18. Initial atypical diagnosis with carcinoma on subsequent prostate needle biopsy: findings at radical prostatectomy.
Chen YB; Pierorazio PM; Epstein JI
J Urol; 2010 Nov; 184(5):1953-7. PubMed ID: 20846684
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer.
Lee CT; Capodieci P; Osman I; Fazzari M; Ferrara J; Scher HI; Cordon-Cardo C
Clin Cancer Res; 1999 May; 5(5):977-83. PubMed ID: 10353729
[TBL] [Abstract][Full Text] [Related]
20. Alpha-methylacyl-CoA racemase (AMACR) in fine-needle aspiration specimens of prostate lesions.
Kaić G; Tomasović-Loncarić C
Diagn Cytopathol; 2009 Nov; 37(11):803-8. PubMed ID: 19459159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
